Anti-H7CR antibodies
US9790277B2 · kind B2 · utility
0Cited by
1References
34Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 23, 2013 |
| Grant date | Oct 17, 2017 |
| Priority date | — |
| Expiry date | Dec 25, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70521
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Antibodies and humanized variants thereof and their antigen-binding fragments and to other molecules that are capable of immunospecifically binding to the B7-H7 counter-receptor, H7CR, and their uses in enhancing immune responses and the treatment and diagnosis of cancer and other diseases are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.